Additional tumour types deriving from non-endocrine cells of the anterior pituitary and the neurophypohysis can be found [3], which pathogenesis is poorly known and will not be considered in this review. 2.1. Classification PA may be classified according to their macroscopic characteristics into micro-(< 1 cm) or macro-adenomas (≥ 1 cm), and enclosed or invasive adenomas. Invasion of the surrounding structures (cavernous sinuses, bone, sphenoidal sinus) is generally defined according to neuroradiological imaging-especially magnetic resonance imaging-, although intraoperative findings may introduce some correction to the pre-operative radiological classification or reveal macroscopic dural invasion. Of note, microscopic evidence of dural invasion is rarely present on surgical samples. The functional classification of PA is based on their hormone-secreting potential, which may be associated with bio-clinical evidence of hormone hypersecretion or recognized by immunohistochemistry (IHC) for pituitary hormones and/or by specific ultrastructural features. From an epidemiological point of view, prolactinomas are by far the most frequent (50-60%), followed by clinically nonfunctioning PA (NFPA) (20-30%), somatotrophinomas (10-15%), corticotrophinomas (5-10%) and thyreotrophinomas (1-2%) [1,2,4]. Recruitment bias are frequently encountered in pathological series, since most prolactinomas are treated by DA only. Clinicopathological correlations in PA have been recently reviewed [4]. In the large majority of PA associated with bio-clinical evidence of hormone secretion, except functional hyperprolactinemia, pathological examination will confirm the diagnosis of PRL, GH, ACTH or TSHsecreting tumours and potentially identify bi-or multi-hormonal secretion. This is especially true for GH-secreting PA, which may also secrete PRL, less frequently glycoprotein hormones, or both (multihormonal). TSH-secreting adenomas are rare and frequently multihormonal. Ultrastructural studies of secreting PA may disclose a "densely granulated" (DG) or "sparsely granulated" (SG) pattern, which may reflect significant differences in hormone secretion and tumour behaviour. This has been well studied in somatotrophinomas, where IHC for cytokeratin can be used to disclose the typical "dot-like" staining pattern of SG adenomas. Although a continuum exists between the SG and DG types, pure SG are typically more aggressive than DG somatotrophinomas [5]. Pathological examination of NFPA may show negative immunostaining for all pituitary hormones (the "null cell" or endocrine inactive histotype), positive immunostaining for FSH and/or LH (gonadotrophinomas) or reveal silent secretion of other pituitary hormones, in particular ACTH and GH ("silent" secreting PA). Cell lineage may also be identified by the expression of specific transcription factors (see "pituitary ontogenesis") [4]. It is generally accepted that most NFPA derive from the gonadotroph lineage, since data obtained from primary cultures or molecular analysis of these tumours frequently rev...